Now showing 1 - 2 of 2
  • 2019Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","87"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Oncology Research and Treatment"],["dc.bibliographiccitation.lastpage","94"],["dc.bibliographiccitation.volume","42"],["dc.contributor.author","Galata, Christian"],["dc.contributor.author","Wimmer, Elisabeth"],["dc.contributor.author","Kasper, Bernd"],["dc.contributor.author","Wenz, Frederik"],["dc.contributor.author","Reißfelder, Christoph"],["dc.contributor.author","Jakob, Jens"],["dc.date.accessioned","2020-11-23T13:31:54Z"],["dc.date.available","2020-11-23T13:31:54Z"],["dc.date.issued","2019"],["dc.description.abstract","The treatment of oligometastatic disease is challenging and few data exist to guide treatment decisions. The objective of this study was to improve the data on the prevalence and treatment of patients with oligometastatic disease."],["dc.identifier.doi","10.1159/000495474"],["dc.identifier.pmid","30814474"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68989"],["dc.language.iso","en"],["dc.relation.eissn","2296-5262"],["dc.relation.issn","2296-5270"],["dc.title","Multidisciplinary Tumor Board Recommendations for Oligometastatic Malignancies: A Prospective Single-Center Analysis"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC
  • 2021Journal Article
    [["dc.bibliographiccitation.firstpage","5659"],["dc.bibliographiccitation.issue","22"],["dc.bibliographiccitation.journal","Cancers"],["dc.bibliographiccitation.volume","13"],["dc.contributor.author","Weigl, Helene"],["dc.contributor.author","Hohenberger, Peter"],["dc.contributor.author","Marx, Alexander"],["dc.contributor.author","Vassos, Nikolaos"],["dc.contributor.author","Jakob, Jens"],["dc.contributor.author","Galata, Christian"],["dc.contributor.editor","Smolle, Maria"],["dc.contributor.editor","Miwa, Shinji"],["dc.date.accessioned","2022-01-11T14:07:50Z"],["dc.date.available","2022-01-11T14:07:50Z"],["dc.date.issued","2021"],["dc.description.abstract","Background: The aim of this study was to investigate diagnostic accuracy, safety and histologic results of ultrasound guided core needle biopsy (CNB) in patients with soft tissue lesions (STL) at a tertiary referral center. Methods: A retrospective analysis of all consecutive patients undergoing ultrasound guided CNB for STL at our sarcoma outpatient service between January 2015 and August 2020 was performed. Results: A total of 392 patients were identified. Main histologic entities were sarcomas, lipomas and desmoid tumors. Biopsy was performed in an outpatient setting in 87.6% of the cases. Conclusive biopsies were obtained in 88.5% of the cases. In patients who underwent surgical resection after CNB, the concordance of dignity, tumor entity and histopathological grading between biopsy and resection specimen were 97.2%, 92.7% and 92.5% respectively. The risk of inconclusive CNB was highest in intraabdominal or retroperitoneal tumors (19.5%) and lowest in lesions at the lower extremity (4.4%). Major complications after CNB occurred in three cases (0.8%). No case of biopsy tract seeding was observed during the study period. Conclusions: Ultrasound guided CNB for STL at first presentation in a dedicated surgical outpatient setting is a safe procedure and yields a high diagnostic accuracy."],["dc.description.abstract","Background: The aim of this study was to investigate diagnostic accuracy, safety and histologic results of ultrasound guided core needle biopsy (CNB) in patients with soft tissue lesions (STL) at a tertiary referral center. Methods: A retrospective analysis of all consecutive patients undergoing ultrasound guided CNB for STL at our sarcoma outpatient service between January 2015 and August 2020 was performed. Results: A total of 392 patients were identified. Main histologic entities were sarcomas, lipomas and desmoid tumors. Biopsy was performed in an outpatient setting in 87.6% of the cases. Conclusive biopsies were obtained in 88.5% of the cases. In patients who underwent surgical resection after CNB, the concordance of dignity, tumor entity and histopathological grading between biopsy and resection specimen were 97.2%, 92.7% and 92.5% respectively. The risk of inconclusive CNB was highest in intraabdominal or retroperitoneal tumors (19.5%) and lowest in lesions at the lower extremity (4.4%). Major complications after CNB occurred in three cases (0.8%). No case of biopsy tract seeding was observed during the study period. Conclusions: Ultrasound guided CNB for STL at first presentation in a dedicated surgical outpatient setting is a safe procedure and yields a high diagnostic accuracy."],["dc.identifier.doi","10.3390/cancers13225659"],["dc.identifier.pii","cancers13225659"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/97877"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-507"],["dc.publisher","MDPI"],["dc.relation.eissn","2072-6694"],["dc.rights","Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)."],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0/"],["dc.title","Accuracy and Safety of Ultrasound-Guided Core Needle Biopsy of Soft Tissue Tumors in an Outpatient Setting: A Sarcoma Center Analysis of 392 Consecutive Patients"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]
    Details DOI